Pricing Log in Create free account

Canton Strategic Holdings, Inc. (CNTN) vs Protara Therapeutics, Inc. (TARA)

Canton Strategic Holdings, Inc. and Protara Therapeutics, Inc. are both Biotechnology companies. Canton Strategic Holdings, Inc. and Protara Therapeutics, Inc. are of similar size ($149.0M and $141.8M). Protara Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Canton Strategic Holdings, Inc. trades at 9.0×. Across the 9 metrics below, Canton Strategic Holdings, Inc. leads on 9 and Protara Therapeutics, Inc. on 0.

Valuation

Metric CNTN TARA Biotechnology median
P/E 9.01 n/m 8.50
P/S n/m n/m 9.71
P/B 0.81 0.88 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 11.10% (57.94%) (33.15%)
Free cash flow yield (6.01%) (46.79%) (25.50%)

Profitability

Metric CNTN TARA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (43.10%) (45.80%) (56.36%)
Return on assets (34.60%) (42.05%) (48.04%)
Return on invested capital (8.11%) (255.06%) 0.00%

Growth

Metric CNTN TARA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 88.10% 38.25% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTN TARA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 15.70 10.97 4.72
Net debt to EBITDA 0.85 2.38 0.96

Dividend

Metric CNTN TARA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTN TARA Biotechnology median
Market cap 149.01m 141.83m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack